Pathogen recognition by innate immunity and its signaling, Proceedings of the Japan Academy, Series B, vol.85, issue.4, pp.143-56, 2009. ,
DOI : 10.2183/pjab.85.143
Human papillomaviruses-related cancers, Human Vaccines & Immunotherapeutics, vol.130, issue.7, p.10, 2014. ,
DOI : 10.1186/1750-9378-7-38
Innate Immunity at the Mucosal Surface: Role of Toll-Like Receptor 3 and Toll-Like Receptor 9 in Cervical Epithelial Cell Responses to Microbial Pathogens1, Increased Toll-like Receptor 9 Expression in Cervical Neoplasia in Tunisian Women, pp.824-855, 2006. ,
DOI : 10.1095/biolreprod.105.048629
Expression of Toll-Like Receptors on Breast Tumors: Taking a Toll on Tumor Microenvironment, International Journal of Breast Cancer, vol.71, issue.5, 2012. ,
DOI : 10.1124/pr.109.001073
The role of inflammation in HPV carcinogenesis, Carcinogenesis, vol.31, issue.11, pp.1905-1917, 2010. ,
DOI : 10.1093/carcin/bgq176
Genetic variation in the TLR and NF-?B pathways and cervical and vulvar cancer risk: a population-based case-control study, 2014. ,
Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy, Molecular Cancer, vol.13, issue.1, p.60, 2014. ,
DOI : 10.1158/1535-7163.MCT-10-0827
A Genetic Variant in the Promoter Region of Toll-Like Receptor 9 and Cervical Cancer Susceptibility, DNA and Cell Biology, vol.31, issue.5, pp.766-71, 2012. ,
DOI : 10.1089/dna.2011.1427
Toll-like receptor 4 signaling promotes the immunosuppressive cytokine production of human cervical cancer, Eur J Gynaecol Oncol, vol.33, pp.291-295, 2012. ,
Polymorphisms of Toll-like receptor 9 are associated with nasopharyngeal carcinoma susceptibility, Tumor Biology, vol.54, issue.4, pp.3247-53, 2014. ,
DOI : 10.1111/j.1348-0421.2010.00248.x
Association between toll-like receptor expression and human papillomavirus type 16 persistence, International Journal of Cancer, vol.11, issue.Suppl 1, pp.879-86, 2011. ,
DOI : 10.1158/1078-0432.CCR-05-0616
URL : http://onlinelibrary.wiley.com/doi/10.1002/ijc.25400/pdf
Toll-Like Receptor Transcriptome in the HPV-Positive Cervical Cancer Microenvironment, Clinical and Developmental Immunology, vol.6, issue.7, p.785825, 2012. ,
DOI : 10.1155/2010/781235
Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells, Anticancer Res, vol.29, pp.2473-78, 2009. ,
Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors, Glia, vol.15, issue.6, pp.526-561, 2006. ,
DOI : 10.4049/jimmunol.165.12.7125
Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers, Cancer Immunology, Immunotherapy, vol.3, issue.Suppl 66, pp.1877-84, 2010. ,
DOI : 10.3233/BD-2002-15109
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence, Cancer Immunology, Immunotherapy, vol.164, issue.18, pp.217-243, 2011. ,
DOI : 10.1016/S0022-5347(05)67457-5
An Exploratory Study of Japanese Fathers' Knowledge of and Attitudes towards HPV and HPV Vaccination: Does Marital Status Matter?, Asian Pacific Journal of Cancer Prevention, vol.15, issue.4, pp.1837-1880, 2014. ,
DOI : 10.7314/APJCP.2014.15.4.1837
TLR9 Expression and Function Is Abolished by the Cervical Cancer-Associated Human Papillomavirus Type 16, The Journal of Immunology, vol.178, issue.5, pp.3186-97, 2007. ,
DOI : 10.4049/jimmunol.178.5.3186
The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter, The Journal of Experimental Medicine, vol.12, issue.7, pp.1369-87, 2013. ,
DOI : 10.1016/j.virol.2004.08.009
Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women, Chinese Journal of Cancer, vol.30, issue.5, pp.344-50, 2011. ,
DOI : 10.5732/cjc.010.10456
Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancer, Trends in Immunology, vol.31, issue.10, pp.391-398, 2010. ,
DOI : 10.1016/j.it.2010.07.004
Human Papillomavirus Deregulates the Response of a Cellular Network Comprising of Chemotactic and Proinflammatory Genes, PLoS ONE, vol.14, issue.3, p.17848, 2011. ,
DOI : 10.1371/journal.pone.0017848.s009
Increased expression of Toll-like receptor 5 during progression of cervical neoplasia, International Journal of Gynecological Cancer, vol.18, issue.2, 2008. ,
DOI : 10.1111/j.1525-1438.2007.01008.x
TLR9-Dependent Recognition of MCMV by IPC and DC Generates Coordinated Cytokine Responses that Activate Antiviral NK Cell Function, Immunity, vol.21, issue.1, pp.107-126, 2004. ,
DOI : 10.1016/j.immuni.2004.06.007
) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer, Journal of International Medical Research, vol.8, issue.4, pp.1027-1063, 2013. ,
DOI : 10.1186/1750-9378-8-4
Increased toll-like receptor 9 expression in cervical neoplasia, Molecular Carcinogenesis, vol.105, issue.11, pp.941-988, 2007. ,
DOI : 10.4049/jimmunol.175.12.8242
Review of the cervical cancer disease burden in mainland China, Asian Pac J Cancer Prev, vol.12, pp.1149-53, 2011. ,
An apple oligogalactan prevents against inflammation and carcinogenesis by targeting LPS/TLR4/NF-??B pathway in a mouse model of colitis-associated colon cancer, Carcinogenesis, vol.31, issue.10, pp.1822-1854, 2010. ,
DOI : 10.1093/carcin/bgq070
Toll-like Receptor 9???mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells, The Journal of Experimental Medicine, vol.83, issue.3, pp.513-533, 2003. ,
DOI : 10.1099/0022-1317-83-7-1535
CpG plus radiotherapy: a review of preclinical works leading to clinical trial, Frontiers in Oncology, vol.2, pp.1-6, 2012. ,
DOI : 10.3389/fonc.2012.00101
Should a Toll-like receptor 4 (TLR-4) agonist antagonist be designed to treat cancer ? TLR-4 : its expression and effects in the most common cancers, Onco targets Ther, vol.6, pp.1573-87, 2013. ,
Expression of toll-like receptor 9 in cervical intraepithelial neoplasia from Mexican women, J Cytol Histol, vol.4, issue.4, 2013. ,
Estimating the costs of cervical screening in high-burden Sub-Saharian African countries, 2014. ,
Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans, Journal of Clinical Investigation, vol.122, issue.11, pp.4118-4147, 2012. ,
DOI : 10.1172/JCI63606DS1
URL : http://www.jci.org/articles/view/63606/files/pdf
The combination of TLR-9 adjuvantation and electroporation-mediated delivery enhances in vivo antitumor responses after vaccination with HPV-16 E7 encoding DNA, International Journal of Cancer, vol.23, issue.14, pp.473-81, 2011. ,
DOI : 10.4049/jimmunol.171.11.5908
Cohort Study. Polymorphism in the promoter region of the Toll-like receptor 9 gene and cervical human papillomavirus infection, 2013. ,
Detection of Human Papillomavirus DNA in Routine Cervical Scraping Samples: Use for a National Cervical Cancer Screening Program in a Developing Nation, Asian Pacific Journal of Cancer Prevention, vol.15, issue.5, pp.2245-2254, 2014. ,
DOI : 10.7314/APJCP.2014.15.5.2245
Evaluation of Toll-like receptors 3 (c.1377C/T) and 9 (G2848A) gene polymorphisms in cervical cancer susceptibility, Molecular Biology Reports, vol.36, issue.7, pp.4715-4736, 2011. ,
DOI : 10.1007/s11033-008-9338-9
Involvement of toll-like receptor 9 polymorphism in cervical cancer development, Molecular Biology Reports, vol.30, issue.8, pp.8425-8455, 2012. ,
DOI : 10.1002/jor.21494
Comparing the effect of Toll-like receptor agonist adjuvants on the efficiency of a DNA vaccine, Archives of Virology, vol.57, issue.8, 2014. ,
DOI : 10.1007/s00262-008-0459-8
Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: An implication for interaction with Helicobacter pylori, International Journal of Medical Microbiology, vol.295, issue.3, pp.179-85, 2005. ,
DOI : 10.1016/j.ijmm.2005.02.009
Immune System's Toll-like Receptors Have Good Opportunity for Cancer Treatment, JNCI: Journal of the National Cancer Institute, vol.98, issue.9, pp.574-579, 2006. ,
DOI : 10.1093/jnci/djj198
URL : https://academic.oup.com/jnci/article-pdf/98/9/574/7688733/djj198.pdf
Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma, World Journal of Gastroenterology, vol.17, issue.32, pp.3745-51, 2011. ,
DOI : 10.3748/wjg.v17.i32.3745
Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia, Leukemia, vol.175, issue.1, pp.53-60, 2007. ,
DOI : 10.1038/nri1391
Innate immunity's path to the Nobel Prize 2011 and beyond, European Journal of Immunology, vol.10, issue.Pt 1, pp.1089-92, 2012. ,
DOI : 10.1038/nri2850
URL : http://onlinelibrary.wiley.com/doi/10.1002/eji.201242404/pdf
TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients, BMC Cancer, vol.167, issue.8, p.415, 2010. ,
DOI : 10.1093/neuonc/nop047
Application of Human Papillomavirus in Screening for Cervical Cancer and Precancerous Lesions, Asian Pacific Journal of Cancer Prevention, vol.14, issue.5, pp.2979-82, 2013. ,
DOI : 10.7314/APJCP.2013.14.5.2979
Human Papillomavirus (HPV) Infection in Women Participating in Cervical Cancer Screening from 2006 to 2010 in Shenzhen City, South China, Asian Pacific Journal of Cancer Prevention, vol.14, issue.12, pp.7483-87, 2006. ,
DOI : 10.7314/APJCP.2013.14.12.7483
Expression of integrins and Toll-like receptors in cervical cancer: Effect of infectious agents, Innate Immunity, vol.108, issue.1, pp.55-69, 2012. ,
DOI : 10.1016/0092-8674(93)90231-E
TLR9 expression and its role in chemosensitivity to DDP in human cervical cancer cells in vitro, Journal of Huazhong University of Science and Technology [Medical Sciences], vol.110, issue.6, pp.550-554, 2011. ,
DOI : 10.1182/blood-2006-09-044776
Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion, Journal of Experimental & Clinical Cancer Research, vol.29, issue.1, p.92, 2010. ,
DOI : 10.1093/jnci/dji403
Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia, Cancer Immunology, Immunotherapy, vol.57, issue.7, pp.1021-1029, 2010. ,
DOI : 10.4049/jimmunol.175.9.6042
Dual character of Toll-like receptor signalling: pro-tumorigenic effects and anti-tumor functions, Bio Bio Acta, vol.1835, pp.144-54, 2013. ,
Toll-Like Receptors in Human Papillomavirus Infection, Archivum Immunologiae et Therapiae Experimentalis, vol.9, issue.7, pp.203-218, 2013. ,
DOI : 10.1016/j.intimp.2008.12.017
Defense against HSV-1 in a murine model is mediated by iNOS and orchestrated by the activation of TLR2 and TLR9 in trigeminal ganglia, Journal of Neuroinflammation, vol.11, issue.1, pp.11-20, 2014. ,
DOI : 10.1186/1742-2094-11-20
Papillomaviruses in the causation of human cancers ??? a brief historical account, Virology, vol.384, issue.2, pp.260-265, 2009. ,
DOI : 10.1016/j.virol.2008.11.046